Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2020-10-10 Purchase |
2020-10-14 4:05 pm |
AKCEA THERAPEUTICS INC. | AKCA | IONIS PHARMACEUTICALS INC 10% Owner |
21,237,715 | $18.15 | $385,464,527 | 98,322,397 (Indirect) |
View |
| 2020-09-22 Sale |
2020-09-24 4:25 pm |
AKCEA THERAPEUTICS INC. | AKCA | Patterson Joshua F. General Counsel |
319 | $18.12 | $5,780 | 26,532 (Direct) |
View |
| 2020-09-22 Sale |
2020-09-24 4:21 pm |
AKCEA THERAPEUTICS INC. | AKCA | Jenne Kyle Chief Commercial Officer |
720 | $18.12 | $13,046 | 52,012 (Direct) |
View |
| 2020-09-22 Sale |
2020-09-24 4:19 pm |
AKCEA THERAPEUTICS INC. | AKCA | McDevitt Damien Chief Executive Officer |
8,709 | $18.12 | $157,807 | 242,978 (Direct) |
View |
| 2020-07-17 Sale |
2020-07-20 5:18 pm |
AKCEA THERAPEUTICS INC. | AKCA | Patterson Joshua F. General Counsel |
263 | $12.5 | $3,288 | 26,851 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2020-10-12 Equity Swap |
2020-10-13 4:04 pm |
N/A N/A |
AKCEA THERAPEUTICS INC. | AKCA | PRICE MICHAEL DENNIS Chief Financial Officer |
50,000 | $18.15 | 0 (Direct) |
View |
| 2020-10-12 Equity Swap |
2020-10-13 4:02 pm |
N/A N/A |
AKCEA THERAPEUTICS INC. | AKCA | Patterson Joshua F. General Counsel |
26,532 | $18.15 | 0 (Direct) |
View |
| 2020-10-12 Equity Swap |
2020-10-13 3:59 pm |
N/A N/A |
AKCEA THERAPEUTICS INC. | AKCA | Jenne Kyle Chief Commercial Officer |
52,012 | $18.15 | 0 (Direct) |
View |
| 2020-10-12 Equity Swap |
2020-10-13 3:58 pm |
N/A N/A |
AKCEA THERAPEUTICS INC. | AKCA | Howarth Alex G. Chief Operating Officer |
66,800 | $18.15 | 0 (Direct) |
View |
| 2020-10-12 Equity Swap |
2020-10-13 3:56 pm |
N/A N/A |
AKCEA THERAPEUTICS INC. | AKCA | Andrews William T. Chief Medical Officer |
37,500 | $18.15 | 0 (Direct) |
View |
| 2020-10-12 Equity Swap |
2020-10-13 3:54 pm |
N/A N/A |
AKCEA THERAPEUTICS INC. | AKCA | McDevitt Damien Chief Executive Officer |
242,978 | $18.15 | 0 (Direct) |
View |
| 2020-08-31 Option Award |
2020-09-02 4:20 pm |
N/A N/A |
AKCEA THERAPEUTICS INC. | AKCA | McDevitt Damien Chief Executive Officer |
1,104 | $14.4 | 251,687 (Direct) |
View |
| 2020-07-09 Option Award |
2020-07-10 5:31 pm |
N/A 2030-07-08 |
AKCEA THERAPEUTICS INC. | AKCA | Andrews William T. Chief Medical Officer |
287,500 | $0 | 287,500 (Direct) |
View |
| 2020-05-18 Option Award |
2020-05-19 5:41 pm |
N/A 2030-05-17 |
AKCEA THERAPEUTICS INC. | AKCA | PRICE MICHAEL DENNIS Chief Financial Officer |
350,000 | $0 | 350,000 (Direct) |
View |